Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress.
about
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a reviewBacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.Promising effect of Magliasa, a traditional Iranian formula, on experimental colitis on the basis of biochemical and cellular findings.ADMET considerations for phosphodiesterase-5 inhibitors.Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.A review of the benefits of Satureja species on metabolic syndrome and their possible mechanisms of action.On the benefit of galls of Quercus brantii Lindl. in murine colitis: the role of free gallic acid.Systemic and metabolic effects of PDE5-inhibitor drugsProtection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain.On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators.Phosphodiesterase inhibitors in inflammatory bowel disease.A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis.Rat Plasma Oxidation Status After Nigella Sativa L. Botanical Treatment in CCL(4)-Treated Rats.Evaluation of the protective effect of pentoxifylline on carrageenan-induced chronic non-bacterial prostatitis in rats.Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial.Electrophysiological and molecular mechanisms of protection by iron sucrose against phosphine-induced cardiotoxicity: a time course study.
P2860
Q26785428-D37960F6-7F0E-4639-BE0D-00372E2F72F3Q35155933-6BFAA1E1-CC76-4F62-93EB-3FC2BE426D90Q36731168-A1C314F1-E252-4284-A3CB-5BEE40572E99Q38024409-BAA69F10-56EE-457B-BAB8-56852CFE8677Q38265958-5D84E28D-8602-4C35-BBD8-2B511D71845BQ38309138-F89859D0-1FCD-4798-8810-4F1EF0E9B02AQ41864184-0C2CE710-724B-4371-950D-0A306F1644C3Q42129412-121C995C-F2C8-4CA6-B5B5-1B768311A444Q43145626-B62B1A8F-396F-4D2A-8269-83BF32B6F65EQ43166900-440D5F49-3BBF-42DD-B2A9-01163E085B3AQ45144546-80D15869-553E-4801-AF3E-13B3F1686AA3Q47861817-C7A5067B-FFBA-45BF-AF85-2D247A3B133AQ48531680-A065C23B-9D33-4B50-9A8D-25FD5D4FA0C1Q50851513-F860C724-DF1D-46D3-8C84-A9402D6F2252Q50873297-5EEEED46-4DE2-4C47-8B4F-99FBC6741A68Q51637495-12A06483-1631-4DA7-8227-594383697CEA
P2860
Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@en
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@nl
type
label
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@en
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@nl
prefLabel
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@en
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@nl
P2093
P2860
P1476
Beneficial effect of phosphodi ...... volvement of oxidative stress.
@en
P2093
Azadeh Mohammadirad
Bagher Minaie
Leila Ashtaral-Nakhai
Mina Bahrololoumi-Shapourabadi
Pooneh Khoshakhlagh
P2860
P304
P356
10.1080/15376510601003769
P577
2007-01-01T00:00:00Z